Clinical value of transrectal ultrasound in the diagnosis of suspected neoplasia in the small pelvis

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

Transrectal ultrasound-guided biopsy successfully diagnosed suspected small pelvis neoplasias in 12 patients, providing adequate tissue for conclusive pathology, especially when CT-guided biopsy failed.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-17 · read from full text

This study evaluated the diagnostic utility of transrectal ultrasound-guided biopsy for verifying suspected pelvic neoplasms in twelve patients with prior unsuccessful CT-guided attempts. The technique successfully obtained high-quality tissue samples for histological diagnosis in all cases, including metastases from urothelial, prostate, cervical, colon, and gastric cancers. Notably, the procedure also identified one case of extragenital endometriosis among the cohort of patients presenting with unclear pelvic masses. Relevance to endometriosis: listed as a differential diagnosis confirmed via biopsy in a patient with suspected pelvic malignancy, though the paper's main focus is on neoplastic conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: In daily clinical practice, it is challenging to accurately diagnose suspected neoplasias in the small pelvis by minimal invasive means, and CT-guided biopsy is often limited in its feasibility. The aim of our study was to evaluate whether transrectal ultrasound (TRUS)-guided biopsy can verify suspected neoplasias in the small pelvis histologically. MATERIAL AND METHODS: The study population consisted of 12 patients who underwent biopsy of suspected malignancy in the pelvis by TRUS. All patients had clinical signs of an advanced tumour stage and in all cases, biopsy utilising computerised tomography (CT scan) had been unsuccessful despite of a documented lesion on CT scan or magnetic resonance imaging. For the TRUS guided biopsy, a commercially available 3-dimensional 7.5-MHz-probe was used (Combison 530 D, GENERAL ELECTRIC, Milwaukee, USA). The probe was armed with an 18 G biopsy gun. RESULTS: In all patients, the suspected lesion was easily detectable by TRUS, and tissue for verification of the malignant origin of the lesions could be collected under real-time TRUS with only 2 patients needing anaesthesia. The biopsy cores were of excellent quality and adequate for conclusive pathological diagnosis. 6 cases of lymph node metastases of a transitional cell carcinoma were detected. 1 case of extended node metastasis in prostate cancer, 1 paravesical manifestation of recurrent cervical cancer, 1 metastasis of a paravesically infiltrating colon cancer and 2 cases of paravesical metastases of a gastric cancer were also diagnosed. In one case, extragenital endometriosis could be diagnosed. CONCLUSION: Based on our experience it can be stated that TRUS-guided biopsy is a reliable diagnostic tool for verification of the neoplastic origin of suspected masses in the small pelvis. In all cases with a history of unsuccessful CT guided biopsy, sufficient tissue cores for conclusive histology could be collected with our technique, and surgical exploration could be avoided. This technique is minimally invasive, without radiation exposure, well tolerated under analgesia, time efficient and cheap.
Full text 8,127 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Purpose: In daily clinical practice, it is challenging to accurately diagnose suspected neoplasias in the small pelvis by minimal invasive means, and CT-guided biopsy is often limited in its feasibility. The aim of our study was to evaluate whether transrectal ultrasound (TRUS)-guided biopsy can verify suspected neoplasias in the small pelvis histologically. Material and Methods: The study population consisted of 12 patients who underwent biopsy of suspected malignancy in the pelvis by TRUS. All patients had clinical signs of an advanced tumour stage and in all cases, biopsy utilising computerised tomography (CT scan) had been unsuccessful despite of a documented lesion on CT scan or magnetic resonance imaging. For the TRUS guided biopsy, a commercially available 3-dimensional 7.5-MHz-probe was used (Combison 530 D, GENERAL ELECTRIC, Milwaukee, USA). The probe was armed with an 18 G biopsy gun. Results: In all patients, the suspected lesion was easily detectable by TRUS, and tissue for verification of the malignant origin of the lesions could be collected under real-time TRUS with only 2 patients needing anaesthesia. The biopsy cores were of excellent quality and adequate for conclusive pathological diagnosis. 6 cases of lymph node metastases of a transitional cell carcinoma were detected. 1 case of extended node metastasis in prostate cancer, 1 paravesical manifestation of recurrent cervical cancer, 1 metastasis of a paravesically infiltrating colon cancer and 2 cases of paravesical metastases of a gastric cancer were also diagnosed. In one case, extragenital endometriosis could be diagnosed. Conclusion: Based on our experience it can be stated that TRUS-guided biopsy is a reliable diagnostic tool for verification of the neoplastic origin of suspected masses in the small pelvis. In all cases with a history of unsuccessful CT guided biopsy, sufficient tissue cores for conclusive histology could be collected with our technique, and surgical exploration could be avoided. This technique is minimally invasive, without radiation exposure, well tolerated under analgesia, time efficient and cheap. Key words TRUS - endorectal biopsy - pelvic neoplasias

Reference

- 1 Hatch K. Pelvic exenteration. Berek JSHN Practical Gynecolic Oncology Philadelphia; Lippincott, Williams and Wilkins 2000: 829-845 - 2 Malmstrom H. Fine-needle aspiration cytology versus core biopsies in the evaluation of recurrent gynecologic malignancies. Gynecol Oncol. 1997; 65 69-73 - 3 Rodriguez L V, Terris M K. Risks and complications of transrectal ultrasound. Curr Opin Urol. 2000; 10 111-116 - 4 Sailer M, Bussen D, Fein M. et al . Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors. J Gastrointest Surg. 2002; 6 342-346 - 5 Arulampalam T H, Costa D C, Loizidou M. et al . Positron emission tomography and colorectal cancer. Br J Surg. 2001; 88 176-189 - 6 Yamashita Y, Harada M, Torashima M. et al . Dynamic MR imaging of recurrent postoperative cervical cancer. J Magn Reson Imaging. 1996; 6 167-171 - 7 Weber T M, Sostman H D, Spritzer C E. et al . Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. Radiology. 1995; 194 135-139 - 8 Seitz K. New goals for contrast-enhanced sonography. Ultraschall in Med. 2005; 26 455-457 - 9 Konopke R, Kersting S, Saeger H D. et al . Detection of liver lesions by contrast-enhanced ultrasound - comparison to intraoperative findings. Ultraschall in Med. 2005; 26 107-113 - 10 Drudi F M, Giovagnorio F, Carbone A. et al . Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy - comparison with MRI. Ultraschall in Med. 2006; 27 146-151 - 11 Wichmann M W, Muller C, Lau-Werner U. et al . The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks Arch Surg. 2000; 385 271-275 - 12 Stroh C, Manger T. Ultrasound diagnosis of rare retrorectal tumors. Zentralbl Chir. 2003; 128 1075-1079 - 13 Albrecht H, Stroszczynski C, Felix R. et al . Real time 3D (4D) ultrasound-guided percutaneous biopsy of solid tumours. Ultraschall in Med. 2006; 27 324-328 - 14 Hunerbein M, Totkas S, Moesta K T. et al . The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery. 2001; 129 164-169 - 15 Weiss H, Duntsch U. Complications of fine needle puncture. DEGUM survey II. Ultraschall in Med. 1996; 17 118-130 - 16 Giede C, Toi A, Chapman W. et al . The use of transrectal ultrasound to biopsy pelvic masses in women. Gynecol Oncol. 2004; 95 552-556 - 17 Gupta R K, Cheung Y K, alAnsari A G. et al . Value of image-guided needle aspiration cytology in the assessment of pelvic and retroperitoneal masses. A study of 112 cases. Acta Cytol. 2003; 47 393-398 - 18 Nagano T, Nakai Y, Taniguchi F. et al . Diagnosis of paraaortic and pelvic lymph node metastasis of gynecologic malignant tumors by ultrasound-guided percutaneous fine-needle aspiration biopsy. Cancer. 1991; 68 2571-2574 Dr. Ludwig Rinnab Urology, University Hospital Prittwitzstreet 43 89075 Ulm Phone: ++49/7 31/50 02 78 07 Fax: ++49/7 31/5 00-2 78 56 Email: [email protected]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Pelvic Neoplasms Ultrasound, High-Intensity Focused, Transrectal Adult Aged Biopsy Carcinoma, Transitional Cell Carcinoma, Transitional Cell Diagnosis, Differential Female Humans Lymphatic Metastasis Lymphatic Metastasis Magnetic Resonance Imaging Male Middle Aged Pelvic Neoplasms Pelvic Neoplasms Pelvic Neoplasms Tomography, X-Ray Computed Treatment Outcome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-19T06:08:28.815611+00:00
pubmed
last seen: 2026-05-13T22:15:00.519696+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine